Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mojaverian

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
The Journal of Pharmacy and Pharmacology|November 1, 1984
Development of an intravenous formulation for the unstable investigational cytotoxic nucleosides 5-azacytosine arabinoside (NSC 281272) and 5-azacytidine (NSC 102816)P Mojaverian, A J Repta
Journal of Pharmaceutical Sciences|June 1, 1980
Production and characterization of specific antibody for radioimmunoassay of procainamideP Mojaverian, G D Chase
Transplantation Proceedings|April 1, 1988
Cyclosporine monitoring in kidney and liver transplant patients: comparison between radioimmunoassay (37 degrees C plasma) and high-performance liquid chromatography (whole blood) measurementsP Mojaverian, P J Green
Journal of Toxicology and Environmental Health|August 1, 1983
Inhibition of sulindac metabolism by dimethyl sulfoxide in the ratB N Swanson, P Mojaverian, V K Boppana
Pharmaceutical Research|November 27, 2013
Morphine inhibition of theophylline clearanceM L Rocci, P Mojaverian, C L Saccar
Pharmaceutical Research|August 1, 1989
Gastrointestinal transit of a solid indigestible capsule as measured by radiotelemetry and dual gamma scintigraphyP Mojaverian, K Chan, A Desai, et al.
European Journal of Pharmacology|February 17, 1984
Enalapril, a new nonsulfhydryl angiotensin converting enzyme inhibitor, does not potentiate morphine analgesiaP Mojaverian, B N Swanson, R K Ferguson
Clinical Pharmacology and Therapeutics|March 1, 1990
Influence of single and multiple doses of oral ranitidine on the gastric transit of an indigestible capsule in humansP Mojaverian, P H Vlasses, S Parker, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 1, 1988
An optimized fluoroenzymatic assay for the determination of angiotensin converting enzyme inhibitors in biological fluidsK Shepley, M L Rocci, H Patrick, et al.
Pharmaceutical Research|October 1, 1988
Effects of gender, posture, and age on gastric residence time of an indigestible solid: pharmaceutical considerationsP Mojaverian, P H Vlasses, P E Kellner, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
The Journal of Pharmacy and Pharmacology|November 1, 1984
Development of an intravenous formulation for the unstable investigational cytotoxic nucleosides 5-azacytosine arabinoside (NSC 281272) and 5-azacytidine (NSC 102816)P Mojaverian, A J Repta
Journal of Pharmaceutical Sciences|June 1, 1980
Production and characterization of specific antibody for radioimmunoassay of procainamideP Mojaverian, G D Chase
Transplantation Proceedings|April 1, 1988
Cyclosporine monitoring in kidney and liver transplant patients: comparison between radioimmunoassay (37 degrees C plasma) and high-performance liquid chromatography (whole blood) measurementsP Mojaverian, P J Green
Journal of Toxicology and Environmental Health|August 1, 1983
Inhibition of sulindac metabolism by dimethyl sulfoxide in the ratB N Swanson, P Mojaverian, V K Boppana
Pharmaceutical Research|November 27, 2013
Morphine inhibition of theophylline clearanceM L Rocci, P Mojaverian, C L Saccar
Pharmaceutical Research|August 1, 1989
Gastrointestinal transit of a solid indigestible capsule as measured by radiotelemetry and dual gamma scintigraphyP Mojaverian, K Chan, A Desai, et al.
European Journal of Pharmacology|February 17, 1984
Enalapril, a new nonsulfhydryl angiotensin converting enzyme inhibitor, does not potentiate morphine analgesiaP Mojaverian, B N Swanson, R K Ferguson
Clinical Pharmacology and Therapeutics|March 1, 1990
Influence of single and multiple doses of oral ranitidine on the gastric transit of an indigestible capsule in humansP Mojaverian, P H Vlasses, S Parker, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 1, 1988
An optimized fluoroenzymatic assay for the determination of angiotensin converting enzyme inhibitors in biological fluidsK Shepley, M L Rocci, H Patrick, et al.
Pharmaceutical Research|October 1, 1988
Effects of gender, posture, and age on gastric residence time of an indigestible solid: pharmaceutical considerationsP Mojaverian, P H Vlasses, P E Kellner, et al.
Pageof 4